TrialClinical pharmacokinetics2016

Blockade of the High-Affinity Interleukin-2 Receptors with Daclizumab High-Yield Process: Pharmacokinetic/Pharmacodynamic Analysis of Single- and Multiple-Dose Phase I Trials.

Mukul Minocha et al.PubMed ↗Publisher ↗

No numbers read from the abstract.